Trial Profile
Induction FOLFOX with or without Aflibercept followed by chemoradiation in High Risk Locally Advanced Rectal Cancer. Phase II randomized, multicenter, open label trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms RIA study
- 16 Mar 2021 Results published in the Clinical Cancer Research
- 31 May 2020 Results of 3-year disease-free suvival and retrospective analysis by molecular subtypes presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 04 Feb 2020 Status changed from active, no longer recruiting to completed.